You are leaving this site
The website you are going to now is not owned by Bioptik Technology Co., Ltd. (our company), but is owned, operated and controlled by its third party. This website does not have any control or control over websites owned by third parties. Controlled permissions, the network link function is only provided for your convenience.

This website and our company are not responsible for the quality, validity, accuracy, completeness, timeliness, legality of the content on the website owned by the third party, nor any comments or links on the website, and have no investigation. Obligation to monitor the quality, effectiveness, accuracy, completeness, timeliness and legality of content on websites owned by third parties. The web link function on this website shall not be construed as a guarantee, endorsement, recommendation or similar statement for any third-party website under any circumstances.

This site and our company hereby expressly declare that they do not assume any express or implied warranty for the quality, effectiveness, accuracy, completeness, timeliness and legality of the content of any third-party website.
Cancel
confirm
Bioptik at MEDICA Asia 2026 | Expanding Global Partnerships
SEPTEMBER 14, 2026
Bioptik at MEDICA Asia 2026 | Expanding Global Partnerships
Bioptik technology team participated in MEDICA Asia 2026, held in Singapore from September 9–11, 2026, connecting with healthcare professionals, distributors, and industry partners from Asia and around the world to showcase the company’s products and solutions in medical diagnostics and healthcare.

At the exhibition, Bioptik showcased a range of core products and services, including blood glucose monitoring systems, wound care medical devices, health supplements, functional foods, and its animal laboratory services. These offerings demonstrate the company’s diverse portfolio, spanning from home health management to professional medical applications. Bioptik has established an integrated health management cycle covering testing, daily health and nutritional care, wound care, and follow-up testing, supported by its in-house product validation platform to ensure functionality and safety.
Through MEDICA Asia 2026, Bioptik engaged in in-depth discussions with potential partners from various countries and regions, gaining a deeper understanding of healthcare needs across Asian markets while actively exploring opportunities for distribution partnerships, product introduction, and international market expansion.

Bioptik will continue to focus on innovative medical technologies and healthcare solutions, further expanding its global presence and working with international partners to promote more convenient, timely, and accessible health management.
Reference
  1. Bioptik x MEDICA Asia 2026 | Healthcare Innovation & Global Partnerships https://www.youtube.com/watch?v=aP63WMHhjcY